Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

bedaquiline

- PMLiVE

TB vaccine disappoints, but others in the pipeline

Failure of first new vaccine in decades will guide development of others, say researchers

Lonafarnib: promising results in first-ever trial for progeria

Treatments for progeria are limited but lonafarnib and FTIs as a class have given renewed hope for children with the condition

- PMLiVE

WHO appoints regional director for the Americas

Dominica’s Dr Carissa Etienne has rich history in healthcare policy

- PMLiVE

Governments need to “get a grip” on hepatitis C

Janssen-backed report says more needs to be done to tackle the “silent pandemic”

- PMLiVE

Janssen’s Zytiga approved for earlier use in Europe

Prostate cancer drug now licensed for use before chemotherapy

- PMLiVE

PatientsLikeMe takes aim at one of world’s rarest diseases

Creates open registry and community for alkaptonuria patients

Janssen boosts vaccines pipeline with GlycoVaxyn deal

Research will focus on targeting multiple bacterial pathogens

- PMLiVE

FDA clears six new drugs in time for the new year

Brings 2012 tally to 39 – the highest for more than 15 years

- PMLiVE

J&J’s TB drug moves closer to US approval

Bedaquiline recommended as treatment for multidrug resistant forms of the disease

- PMLiVE

England’s chief medical officer warns of rising liver disease rates

First annual report also provides data to help improve public health efforts in the country

- PMLiVE

Access to AIDS treatment up by two thirds as countries increase investment

UNAIDS report says 8 million people in developing nations are now receiving antiretroviral therapy

- PMLiVE

ECDC appoints France’s Françoise Weber as chair

Tiiu Aro of Estonia elected deputy chair of the European Centre for Disease Prevention and Control

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links